Home > Journals > Minerva Ginecologica > Past Issues > Articles online first > Minerva Ginecologica 2017 Mar 07

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

Minerva Ginecologica 2017 Mar 07

DOI: 10.23736/S0026-4784.17.04042-4

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Ovarian cancer in endometriosis. Clinical and molecular aspects: an update

Rachel RUDERMAN, Mary E. PAVONE

Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA


PDF  


While endometriosis is a benign condition, the presence of endometriosis has been associated with the development of several types of cancers, including ovarian. Endometriomas, or ovarian endometriotic cysts, are found in 17-44% of patients with endometriosis, and may be a common precursor lesions to ovarian cancer. Endometriosis associated ovarian cancer is especially prominent in endometrioid and clear cell ovarian tumor histological subtypes. Several common pathways linking endometriosis and ovarian cancer have been elucidated, including the dominance of certain cytokines, oxidative stress, and a hyper-estrogenic hormonal milieu, which propagate both endometriosis and endometriosis associated ovarian cancer. Additionally, genetic mutations including PTEN, PIK3CA, ARID1A, Wnt/ beta-catenin, microsatellite instability, Src, and KRAS have been shown to be critical in the pathogenesis of endometriosis associated ovarian cancers. Research continues to develop and provide insights into various prevention, screening, and treatment modalities. In this article, we present a comprehensive review of our current knowledge on this topic in both a clinical and molecular context.


KEY WORDS: Ovarian cancer - Endometriosis - Cancer - EAOC

top of page

Publication History

Cite this article as

Corresponding author e-mail

m-pavone@northwestern.edu